Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
October 14, 2016
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016
Yuri P Springer, Roy Gerona, Erich Scheunemann, et al.
ACS Chemical Neuroscience
|
October 15, 2020
Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA
Adam Ametovski, Christa Macdonald, Jamie J Manning, et al.
Drug Testing and Analysis
|
April 28, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays
Katharina Elisabeth Grafinger, Marthe M Vandeputte, Annelies Cannaert, et al.
ACS Chemical Neuroscience
|
April 5, 2013
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse
Samuel D Banister, Shane M Wilkinson, Mitchell Longworth, et al.
ACS Chemical Neuroscience
|
April 10, 2024
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
Eric Sparkes, Axelle Timmerman, Jack W Markham, et al.
European Journal of Medicinal Chemistry
|
April 2, 2015
Structure-activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs
Corinne Beinat, Tristan Reekie, Samuel D Banister, et al.
Drug Testing and Analysis
|
March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs
Samuel D Banister, Richard C Kevin, Lewis Martin, et al.
Plos One
|
February 19, 2013
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats
Hervé Boutin, Christian Prenant, Renaud Maroy, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Samuel D Banister, Michael Moir, Jordyn Stuart, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
MMWR. Morbidity and Mortality Weekly Report
|
October 14, 2016
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016
Yuri P Springer, Roy Gerona, Erich Scheunemann, et al.
ACS Chemical Neuroscience
|
October 15, 2020
Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA
Adam Ametovski, Christa Macdonald, Jamie J Manning, et al.
Drug Testing and Analysis
|
April 28, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays
Katharina Elisabeth Grafinger, Marthe M Vandeputte, Annelies Cannaert, et al.
ACS Chemical Neuroscience
|
April 5, 2013
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse
Samuel D Banister, Shane M Wilkinson, Mitchell Longworth, et al.
ACS Chemical Neuroscience
|
April 10, 2024
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
Eric Sparkes, Axelle Timmerman, Jack W Markham, et al.
European Journal of Medicinal Chemistry
|
April 2, 2015
Structure-activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs
Corinne Beinat, Tristan Reekie, Samuel D Banister, et al.
Drug Testing and Analysis
|
March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs
Samuel D Banister, Richard C Kevin, Lewis Martin, et al.
Plos One
|
February 19, 2013
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats
Hervé Boutin, Christian Prenant, Renaud Maroy, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Samuel D Banister, Michael Moir, Jordyn Stuart, et al.
Page
of 9